OUR PRODUCTS

MOBILE APPS

GENERAL INFO

CCCC

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

C4 Therapeutics (CCCC) Earnings Date & Reports

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients’ lives... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CCCC is expected to report earnings to rise 12.43% to -41 cents per share on October 30

C4 Therapeutics CCCC Stock Earnings Reports

Q3'25

Est.

$-0.42

Q2'25

Beat

by $0.03

Q1'25

Beat

by $0.09

Q4'24

Est.

$-0.49

Q3'24

Beat

by $0.03

The last earnings report on August 07 showed earnings per share of -37 cents, beating the estimate of -40 cents. With 360.49K shares outstanding, the current market capitalization sits at 177.52M.

View a ticker or compare two or three

Compare

CCCC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For CCCC
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CCCC showed earnings on August 07, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

490 Arsenal Way

Phone

+1 617 231-0700

Employees

145

Web

https://www.c4therapeutics.com